-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/metanalysis-proportion-rate-comparison_research.pdf
November 01, 2013 - Simulation scenario is denoted by 𝑗; the specific random simulation under scenario 𝑗 is denoted by … 𝑖 for scenario j is denoted by 𝜋�𝚤𝚥. … The index j for the
scenario has been dropped. … The
following pseudo-algorithm describes the process for scenario j (all subscripts for the scenario … This scenario is labeled S1.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/integrating-evidence_methods.pdf
February 01, 2015 - • Scenario 3: Use review with new or modified analysis
• Scenario 4: Use selected elements of review … A-1
Scenarios
Scenario 1: Use existing review without modifying or adding new studies
Scenario … 2: Use review and add new studies
Scenario 3: Use review with new or modified analysis
Scenario 4: … Scenario-Specific Considerations
Scenario 1: Use existing review without modifying or adding new studies … Scenario 5: Don’t use review
1.
-
effectivehealthcare.ahrq.gov/products/metanalysis-proportion-rate-comparison/research
November 04, 2013 - For each scenario we generated 1000 random meta-analyses, on which we applied fixed and random effects
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-assessing-impact.pdf
September 01, 2018 - 1
without
Enhancement
Time to Find
Answer in
Scenario 1
with
Enhancement
Time to Find
Answer … in
Scenario 2
without
Enhancement
Time to Find
Answer in
Scenario 2
with
Enhancement
Health-System … in
Scenario 2
without
Enhancement
Time to Find
Answer in
Scenario 2 with
Enhancement
Pharmacy … AMDA Process None 2-4
Scenario 1: Your health system employs many treatment strategies for UI with … AMDA Process None 1-4
Scenario 2: According to guidelines, modifiable UI causes should be identified
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/data-repository-reviews_white-paper.pdf
September 01, 2012 - We excluded a third scenario, commercial or fee-for-service operation, because we felt it
counter to … Funding Scenario 1–Federal Government
Under this scenario, the daily operation of the system could … In a slight variation on this scenario, the SRDR could be funded by the new legislatively
mandated, … Funding Scenario 2–Independent Nonprofit
In the second scenario, SRDR would operate as an independent … This model could be adapted to a scenario in which much of the responsibility for SRDR is
assumed by
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-decision-models_methods.pdf
July 01, 2012 - Scenario A: In patients with dementia, can PET be used to determine the type of
dementia that would … Scenario B: For patients with mild cognitive impairment, could PET be used to identify a
group of patients … Scenario C: Is the available evidence enough to justify the use of PET to identify a group
of patients … typical
examination) or where it triages who will receive the clinical examination (an unrealistic
scenario … of people with mild cognitive impairment (MCI) in the initial clinical exam
(scenario B above).
-
effectivehealthcare.ahrq.gov/products/bayesian-mixed-treatment/research
January 31, 2013 - Findings of Bayesian Mixed Treatment Comparison Meta-Analyses: Comparison and Exploration Using Real-World Trial Data and Simulation
Research Report January 31, 2013 Web Version [NLM Site] Download Main Document PDF 2.4 MB
People using assistive technology may not be able to fully access information in …
-
effectivehealthcare.ahrq.gov/sites/default/files/ijzerman_ahrq-webinar-mcda.pdf
January 01, 2011 - Dia 1
1
Integrating stakeholder preferences in
comparative effectiveness research
using multi-criteria decision analysis
(MCDA) and Conjoint Analysis (CA)
Maarten J. IJzerman, PhD
Professor and chair, department Health Technology &
Services Research
m.j.ijzerman@utwente.nl
Multiple endpoints in …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-decision-modeling.ppt
June 01, 2012 - Scenario A: The clear winner is indicated by direct comparative evidence that:
Evaluates all important … term=16754927
Scenario B: One test-and-treat strategy can be a clear winner as demonstrated by test … Scenario C: Is the available evidence enough to justify the use of PET to identify a group of patients … In Scenario A, where patients have dementia, can PET be used to determine the type of dementia that would … In Scenario B, where patients have mild cognitive impairment, could PET be used to identify a group of
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-decision-modeling.ppt
June 01, 2012 - Scenario A: The clear winner is indicated by direct comparative evidence that:
Evaluates all important … term=16754927
Scenario B: One test-and-treat strategy can be a clear winner as demonstrated by test … Scenario C: Is the available evidence enough to justify the use of PET to identify a group of patients … In Scenario A, where patients have dementia, can PET be used to determine the type of dementia that would … In Scenario B, where patients have mild cognitive impairment, could PET be used to identify a group of
-
effectivehealthcare.ahrq.gov/products/genetic-tests-validity-rating-evaluation/research
June 16, 2011 - Addressing Challenges in Genetic Test Evaluation: Evaluation Frameworks and Assessment of Analytic Validity
Research Report June 16, 2011 Web Version [NLM Site] Download Main Document PDF 918 KB
Persons using assistive technology may not be able to fully access information in this file. ;For assistance,…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-3.pdf
February 01, 2018 - Describe a scenario for which a fixed effects versus random effects model
may be appropriate.
2. … well-approximated by the normal
distribution; model choice is complex.
► The DL method performs poorly in this scenario … 16015676. http://dx.doi.org/10.1002/sim.2112
Summary of objective 1
Objective: Be able to describe a scenario
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
January 01, 2011 - Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA)
Slide 1
Integrating stakeholder preferences in comparative effectiveness research using
multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA)
Maarten J…
-
effectivehealthcare.ahrq.gov/products/horizon-scan/research-2015
October 01, 2015 - This scenario assumed availability and implementation of all interventions in the estimated patient populations
-
effectivehealthcare.ahrq.gov/products/registries-linking-records-methods/research
September 29, 2014 - Linking Data for Health Services Research: A Framework and Instructional Guide
Research Report September 29, 2014 Web Version [NLM Site] Download Main Document PDF 1 MB
People using assistive technology may not be able to fully access information in these files. For additional assistance, please contac…
-
effectivehealthcare.ahrq.gov/products/stakeholders-engagement-others/research-2012
January 24, 2012 - The Facilitation Primer: Strategies, Tools & Considerations to Get You Started
Research Report January 24, 2012 Download Main Document PDF 462.3 KB
This document is available in PDF (462 kB) only. People using assistive technology may not be able to fully access information in this file. For additiona…
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
January 01, 2010 - Panel A shows a scenario in
which there is a “threshold effect”—where the
benefit (or risk) associated … In defining exposure under
this scenario, it would be important to define the
cumulative amount of … Panel F represents a
scenario where the effect from a single exposure
is not immediate but happens … The final
scenario is panel I, which shows a large change
in risk/benefit upon initial exposure and … not accounted for in the analysis of study data.12
Over-the-counter (OTC) medications present
a scenario
-
effectivehealthcare.ahrq.gov/sites/default/files/s23.pdf
October 01, 2007 - contraceptives, PPA is likely
to be 10 times less harmful in terms of stroke in the least
conservative scenario … and probably equally harmful in the
most conservative scenario. … helpful for communicating
the chance of experiencing an event (either benefit or a
harm).9,29 In our scenario … There is also an intermediate scenario, with
some women completely relieved, some having reduc-
tions
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-research-report-integrating-health-system-data.pdf
April 01, 2020 - Integrating Health System Data With Systematic Reviews_Methods Research Report
Methods Research Report
Integrating Health System Data With Systematic
Reviews: A Framework for When and How
Unpublished Health System Data Can Be Used With
Systematic Reviews To Support Health System
Decision Making
Methods Rese…
-
effectivehealthcare.ahrq.gov/sites/default/files/exposure-definition-and-measurement_chapter-4.pptx
January 01, 2013 - Example 2 (analogous scenario for nonpharmacological interventions): In a study examining a multivisit … Panel A shows a scenario in which there is a “threshold effect”—where the benefit (or risk) associated … Panel F represents a scenario where the effect from a single exposure is not immediate but happens relatively